Abbott Laboratories (NYSE:ABT) Price Target Raised to $147.00
Abbott Laboratories (NYSE:ABT – Free Report) had its price target increased by Wells Fargo & Company from $136.00 to $147.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have an overweight rating on the healthcare product maker’s stock. Other research analysts have also issued research reports about the stock. UBS […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price target increased by Wells Fargo & Company from $136.00 to $147.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have an overweight rating on the healthcare product maker’s stock. Other research analysts have also issued research reports about the stock. UBS […]
